Elsevier

Bone

Volume 18, Issue 2, February 1996, Pages 75-85
Bone

Review article
Bisphosphonates: A review of their pharmacokinetic properties

https://doi.org/10.1016/8756-3282(95)00445-9Get rights and content

Abstract

Bisphosphonates are a unique class of drugs. As a family, they are characterized pharmacologically by their ability to inhibit bone resorption, whereas, pharmacokinetically, they are classified by their similarity in absorption, distribution, and elimination. Although all bisphosphonates have similar physicochemical properties, their antiresorbing activities differ substantially. Activity is dramatically increased when the amino group is contained in the aliphatic carbon chain. For example, alendronate, an aminobisphosphonate, is approximately 700-fold more potent than etidronate, both in vitro and in vivo. In general, bisphosphonates are poorly absorbed from the gastrointestinal tract as a result of their poor lipophilicity. In vitro and in vivo studies have shown that bisphosphonates are absorbed from the gastrointestinal tract via paracellular transport. Systemically available bisphosphonates disappear very rapidly from plasma, and are partly taken up by the bone and partly excreted by the kidney. The relative contribution of these two processes to overall plasma elimination differs significantly among bisphosphonates. To date, all bisphosphonates studied show no evidence of metabolism. Renal excretion is the only route of elimination. Studies with alendronate in rats indicate that the drug is actively secreted by an uncharacterized renal transport system, and not by the anionic or cationic renal transport systems. Bisphosphonates bind preferentially to bones which have high turnover rates, and their distribution in bone is not homogeneous. After bone uptake, the bisphosphonates are liberated again only when the bone in which they are deposited is resorbed. Thus, the half-life of bisphosphonates in bone is very long, ranging among different species from 1 to 10 years, depending largely on the rate of bone turnover.

References (96)

  • U. Kragh-Hansen et al.

    Protein binding of small molecules I. Effect of pH and inorganic salts on the combination of phenol red with proteins

    Biochem Biophys Acta

    (1973)
  • J.H. Lin et al.

    On the absorption of alendronate in rats

    J Pharm Sci

    (1994)
  • W.R. Michael et al.

    Metabolism of disodium ethane-1-hydroxy-1, 1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey

    Toxicol Appl Pharmacol

    (1972)
  • R.R. Recker et al.

    Intestinal absorption of disodium ethane-1-hydroxyl-1-diphosphonate (disodium eidronate) using a deconvolution technique

    Toxicol Appl Pharmacol

    (1973)
  • P.G. Ruifrok et al.

    Paracellular transport of inorganic and organic ions across the rat ileum

    Biochem Pharmacol

    (1983)
  • U. Troehler et al.

    Renal secretion of diphosphonates in rats

    Kidney Int

    (1975)
  • I.M. Twiss et al.

    Cytotoxic effects of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport

    J Pharm Sci

    (1994)
  • E.J. Arie n̋s

    Excursions in the field of SAR: a consideration of the past, the present and the future

  • J.A. Arie n̋s et al.

    Optimalization of pharmacokinetics-An essential aspect of drug development

  • W.M. Armstrong et al.

    Electrical phenomena and ion transport in the small intestine

  • G.D. Aurbach

    Calcium-regulating hormones: parathyroid hormone and calcitonin

  • O.L.M. Bijvoet et al.

    APD in Paget's disease of bone. Role of mononuclear phagocyte system?

    Arth Rheum

    (1980)
  • K.A. Conrad et al.

    Clodronate kinetics and dynamics

    Clin Pharmacol Ther

    (1981)
  • P.T. Daley-Yates et al.

    A comparison of the pharmacokinetics of 14C-labelled APD and 99m Tc-labelled ADP in the mouse

    Calcif Tissue Int

    (1988)
  • P.T. Daley-Yates et al.

    The clearance and bioavailability of pamidronate in patients with breast cancer and bone metastases

    Calcif Tissue Int

    (1991)
  • E.F. Eriksen et al.

    Trabecular bone remodeling and bone balance in hyperthyroidism

    Bone

    (1984)
  • A. Fitton et al.

    Pamidronate: a review of its pharmacological properties and therapeutic efficiency in resorptive bone disease

    Drugs

    (1991)
  • H. Fleisch

    Bisphosphonates. Mechanism of action and clinical applications

  • H. Fleisch

    Bone and mineral metabolism

  • H. Fleisch et al.

    Diphosphonates

    Calcif Tissue Int

    (1979)
  • H. Fleisch et al.

    The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution of calcium phosphate in vitro and in vivo

    Calcif Tissue Res

    (1968)
  • H. Fleisch et al.

    Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo

    Science

    (1969)
  • H. Fleisch et al.

    Pyrophosphate and polyphosphate

  • H. Fleisch et al.

    Effect of pyrophosphonate on hydroxyapatite and its implications in calcium homeostasis

    Nature

    (1966)
  • I. Fogelman et al.

    Absorption of oral disphosphonates in normal subjects

    Clin Endocrinol

    (1986)
  • B.J. Gertz et al.

    Clinical pharmacology of alendronate sodium

    Osteopor Int

    (1993)
  • M. Gibaldi et al.

    Absorption kinetics and bioavailability

  • J. Greven

    Renal transport of drugs. Renal transport of organic substances

  • R.P. Gural et al.

    Dosedependent absorption of disodium etidronate

    J Pharm Pharmacol

    (1985)
  • H. Hanhijäri et al.

    Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days

    Int J Clin Pharmacol Ther Toxicol

    (1989)
  • J.A. Henry et al.

    A model for the pH dependency of drug-protein binding

    J Pharm Pharmacol

    (1981)
  • W.R. Hewitt et al.

    The renal excretion of drugs

  • Z. Hu

    Glucose effects on intestinal drug absorption: contributions of microclimate pH and paracellular pathway

  • L. Hyldstrup et al.

    Pharmacokinetic evaluation of pamidronate after oral administration: a study on dose proportionality, absolute bioavailability, and effect of repeated administration

    Calcif Tissue Int

    (1993)
  • M. Janner et al.

    Sodium EDTA enhances intestinal absorption of two bisphosphonates

    Calcif Tissue lot

    (1991)
  • B.G. Julio et al.

    Selective flame emission detection of phosphorus and sulfur in high-performance liquid chromatography

    J Chromatogr

    (1975)
  • A. Jung et al.

    The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals

    Calcif Tissue Res

    (1973)
  • A.J. Kahn et al.

    Structure-function relationships in bone: an examination of events at the cellular level

  • Cited by (824)

    View all citing articles on Scopus
    View full text